What is Getlabs?
Founded in 2018, Getlabs operates at the intersection of logistics and clinical diagnostics. The company provides a seamless interface for patients to schedule certified phlebotomists for home visits, ensuring that essential blood work and diagnostic testing are accessible without the friction of traditional clinical visits. By integrating directly with major diagnostic networks, Getlabs has positioned itself as a critical infrastructure layer in the evolving digital health ecosystem. Its market position is defined by its ability to scale high-touch medical services through a technology-enabled workforce, addressing the increasing consumer preference for on-demand, home-based healthcare delivery.
How much funding has Getlabs raised?
Getlabs has raised a total of $23M across 2 funding rounds:
Angel/Seed
$3M
Series A
$20M
Angel/Seed (2021): $3M with participation from PivotNorth Capital
Series A (2022): $20M led by The Minderoo Foundation and Emerson Collective
Key Investors in Getlabs
PivotNorth Capital
Pivot North Capital is a venture capital firm that focuses on early-stage technology companies, providing funding and strategic support to help startups scale in competitive markets.
Emerson Collective
Emerson Collective invests in purpose-driven entrepreneurs and innovators, focusing on addressing complex societal challenges through audacious ideas and rigorous thinking.
The Minderoo Foundation
The Minderoo Foundation is a philanthropic organization that drives positive change through initiatives in ocean research, community projects, and global health, including significant pandemic-related support.
What's next for Getlabs?
With this major strategic investment, Getlabs is well-positioned to accelerate its geographic expansion and enhance its technological infrastructure. The company is expected to focus on optimizing its logistics platform to increase the density of its phlebotomy network, thereby reducing wait times and improving service reliability. Furthermore, the capital will likely support deeper integrations with healthcare providers and insurance networks, solidifying its role as a standard-bearer for home-based diagnostic services. As the company matures, the focus will shift toward long-term sustainability and the potential for broader diagnostic service offerings, leveraging its established trust and operational efficiency to capture a larger share of the growing remote-care market.
See full Getlabs company page
